InterventionsHumans
MON-690 Impact of GLP-1 Receptor Agonists on Late Complications Following Bariatric Surgery
ENDO 2025 Abstract
The paper
Gadalla K, Blocher N, Ali S et al.
ENDO 2025 Abstract · 22 Oct 2025 · CC BY-NC-ND
Presented at ENDO 2025
Related
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026